Search

Your search keyword '"Chris Nicholas Hurt"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Chris Nicholas Hurt" Remove constraint Author: "Chris Nicholas Hurt"
75 results on '"Chris Nicholas Hurt"'

Search Results

1. Technique for inguino-femoral lymph node dissection in vulvar cancer: an international survey

2. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial

3. Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

4. Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer

5. Medullary Thyroid Cancer Patient’s Assessment of Quality of Life Tools: Results from the QaLM Study

6. Outcome of Weekly Carboplatin–Paclitaxel-based Definitive Chemoradiation in Oesophageal Cancer in Patients Not Considered to be Suitable for Platinum–Fluoropyrimidine-based Treatment: A Multicentre, Retrospective Review

8. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT

9. Human Papillomavirus DNA Methylation Predicts Response to Treatment Using Cidofovir and Imiquimod in Vulval Intraepithelial Neoplasia 3

10. Deintensification of Adjuvant Treatment After Transoral Surgery in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer: The Conception of the PATHOS Study and Its Development

11. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer

12. Radiotherapy after esophageal cancer stenting (ROCS): A pragmatic randomized controlled trial evaluating the role of palliative radiotherapy in maintaining swallow

13. Translational analysis from SCALOP trial: CCL5 as a prognostic biomarker and a potentially actionable target in locally advanced pancreatic cancer (LAPC)

14. Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial

15. Patient understanding and acceptability of an early lung cancer diagnosis trial:a qualitative study

16. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial

17. Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer

18. Tu2012 - Feasibility and Economic Evaluation of Chromoendoscopy for Detecting Proximal Serrated Neoplasia in a Colorectal Cancer Screening Program: A Randomised Control Trial – Conscop

19. PO-0796 Carbotaxol definitive chemoradiotherapy for inoperable oesophageal cancer: UK multicentre study

20. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer

21. Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial

22. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial

23. CCL5 is associated with poor prognosis in locally advanced pancreatic cancer (LAPC): biomarker analysis from the randomised phase II SCALOP trial

24. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

25. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cencer: Analysis of the on-trial cases for the SCALOP trial

26. The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation

27. Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer

28. Vaccination timing of low-birth-weight infants in rural Ghana: a population-based, prospective cohort study

29. Toward Semi-automated Assessment of Target Volume Delineation in Radiotherapy Trials: The SCOPE 1 Pretrial Test Case

30. Effect of vitamin A supplementation on cause-specific mortality in women of reproductive age in Ghana: a secondary analysis from the ObaapaVitA trial

31. Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies

32. Definitive Chemoradiation for Oesophageal Cancer — a Standard of Care in Patients with Non-metastatic Oesophageal Cancer

33. PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer

34. Aetiology of stillbirths and neonatal deaths in rural Ghana: implications for health programming in developing countries

35. NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma

36. Cancer risks in populations living near landfill sites in Great Britain

37. Stomach Dose-Volume Parameters and Clinical Factors Predict Acute Toxicity in Pancreatic Cancer Chemoradiotherapy

38. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial

39. Cardiovascular Disease: Calcium Channel Anomalies

40. PO-0986: Can radiotherapy dose distribution be related to outcome? An analysis of the SCOPE 1 oesophageal cancer trial data

41. PD-0526: Robustness of integrated boost plans for oesophageal cancer: arctherapy vs intensity-modulated proton therapy

42. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial

43. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial

44. P-222 Analysis of tumour contours and radiotherapy planning of 'on-trial' patients undergoing chemoradiotherapy (CRT) in SCALOP trial: does pre-trial Radiotherapy Quality Assurance (RTQA) improve the quality of 'on-trial' radiotherapy?

45. O-003 Long-term outcome from the SCALOP trial: a multi-centre randomized phase II trial of gemcitabine or capecitabine-based chemoradiation (CRT) for locally advanced pancreatic cancer (LAPC)

47. Long term results and patterns of recurrence from SCOPE 1: A phase II/III randomised trial of definitive chemoradiotherapy (dCRT) plus or minus cetuximab (dCRT+C) in esophageal cancer

48. Role of nutritional status as predictor of survival in oesophageal cancer treated with definitive chemoradiation (dCRT): outcome from SCOPE1, a phase II/III randomised trial of dCRT +/- cetuximab

49. NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine (OXCAP) or carboplatin/paclitaxel (CarPac) based chemoradiation (CRT) as pre-operative regimen for resectable oesophageal adenocarcinoma

50. Are women ready for the new cervical screening protocol in England A systematic review and qualitative synthesis of views about human papillomavirus testing

Catalog

Books, media, physical & digital resources